Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam J Smith

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Journal of Medical Genetics|February 19, 2020
Association between genetic polymorphisms and endometrial cancer risk: a systematic reviewCemsel Bafligil, Deborah J Thompson, Artitaya Lophatananon, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 8, 2023
Validation of lung cancer polygenic risk scores in a high-risk case-control cohortMikey B Lebrett, Miriam J Smith, Emma J Crosbie, et al.
Oncogene|December 2, 2020
The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meningesDaniel M Fountain, Miriam J Smith, Claire O'Leary, et al.
European Journal of Human Genetics : EJHG|August 28, 2014
Common variants modify the age of onset for basal cell carcinomas in Gorlin syndromeBinnaz Yasar, Helen J Byers, Miriam J Smith, et al.
Clinical Genetics|September 29, 2021
Dominant-negative pathogenic variant BRIP1 c.1045G>C is a high-risk allele for non-mucinous epithelial ovarian cancer: A case-control studyNicola Flaum, Elke M van Veen, Olivia Smith, et al.
American Journal of Medical Genetics. Part A|November 23, 2011
Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosisMiriam J Smith, Anjana Kulkarni, Cecilie Rustad, et al.
Neurogenetics|March 22, 2012
Frequency of SMARCB1 mutations in familial and sporadic schwannomatosisMiriam J Smith, Andrew J Wallace, Naomi L Bowers, et al.
Neuro-Oncology Advances|March 19, 2026
A systematic review and meta-analysis of outcomes following active surveillance, surgery and radiotherapy of meningiomas in NF2-related schwannomatosisJack Sheppard, Siddarth Kannan, Jane Halliday, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 15, 2022
Development and evaluation of polygenic risk scores for prediction of endometrial cancer risk in European womenCemsel Bafligil, Deborah J Thompson, Artitaya Lophatananon, et al.
Clinical Biochemistry|December 25, 2012
Plasma S100β is not a useful biomarker for tumor burden in neurofibromatosisMiriam J Smith, Sonia Esparza, Vanessa L Merker, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Journal of Medical Genetics|February 19, 2020
Association between genetic polymorphisms and endometrial cancer risk: a systematic reviewCemsel Bafligil, Deborah J Thompson, Artitaya Lophatananon, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 8, 2023
Validation of lung cancer polygenic risk scores in a high-risk case-control cohortMikey B Lebrett, Miriam J Smith, Emma J Crosbie, et al.
Oncogene|December 2, 2020
The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meningesDaniel M Fountain, Miriam J Smith, Claire O'Leary, et al.
European Journal of Human Genetics : EJHG|August 28, 2014
Common variants modify the age of onset for basal cell carcinomas in Gorlin syndromeBinnaz Yasar, Helen J Byers, Miriam J Smith, et al.
Clinical Genetics|September 29, 2021
Dominant-negative pathogenic variant BRIP1 c.1045G>C is a high-risk allele for non-mucinous epithelial ovarian cancer: A case-control studyNicola Flaum, Elke M van Veen, Olivia Smith, et al.
American Journal of Medical Genetics. Part A|November 23, 2011
Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosisMiriam J Smith, Anjana Kulkarni, Cecilie Rustad, et al.
Neurogenetics|March 22, 2012
Frequency of SMARCB1 mutations in familial and sporadic schwannomatosisMiriam J Smith, Andrew J Wallace, Naomi L Bowers, et al.
Neuro-Oncology Advances|March 19, 2026
A systematic review and meta-analysis of outcomes following active surveillance, surgery and radiotherapy of meningiomas in NF2-related schwannomatosisJack Sheppard, Siddarth Kannan, Jane Halliday, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 15, 2022
Development and evaluation of polygenic risk scores for prediction of endometrial cancer risk in European womenCemsel Bafligil, Deborah J Thompson, Artitaya Lophatananon, et al.
Clinical Biochemistry|December 25, 2012
Plasma S100β is not a useful biomarker for tumor burden in neurofibromatosisMiriam J Smith, Sonia Esparza, Vanessa L Merker, et al.
Pageof 9